Zipdrug

Zipdrug is a NYC-based venture-backed healthcare technology company revolutionizing the pharmacy experience for health plans and their members. Zipdrug’s proprietary technology leverages delivery to narrow pharmacy networks, better aligning payers, PBMs, patients and pharmacies resulting in reduced costs, improved medication adherence, and higher-quality member experiences.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BIOGX AND BOSCH HEALTHCARE SOLUTIONS ANNOUNCE PARTNERSHIP TO DEVELOP INFECTIOUS DISEASE TESTS FOR THE VIVALYTIC PLATFORM

BioGX and Bosch Healthcare Solutions | May 27, 2020

news image

BioGX and Bosch Healthcare Solutions have partnered to develop point-of-care infectious disease tests for the Bosch Vivalytic all-in-one platform. Vivalytic is a universal sample-to-result platform for molecular diagnostics which can be used at the point-of-need. The patient sample is placed into the test cartridge, which is then inserted into the Vivalytic analyzer. Since the cartridge already contains all the necessary reagents, the test can be conducted with full automation and a faster turna...

Read More

FUTURE OF HEALTHCARE

R1 RCM TO ACQUIRE CLOUDMED, CREATING THE STRATEGIC REVENUE PARTNER FOR HEALTHCARE PROVIDERS

R1 RCM | January 11, 2022

news image

R1 RCM Inc., a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to acquire Cloudmed, a leader in Revenue Intelligence™ solutions for healthcare providers, in an all-stock transaction. The transaction values Cloudmed at approximately $4.1 billion, including $857 million of net debt, based on R1’s closing stock price on January 7, 20...

Read More

HEALTH TECHNOLOGY

IVENIX TO BE ACQUIRED BY FRESENIUS KABI

Ivenix | April 01, 2022

news image

Ivenix, Inc. announced that it has entered into a definitive agreement to be acquired by Fresenius Kabi, a global health care leader specializing in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Ivenix’s advanced infusion system combined with Fresenius Kabi’s intravenous fluids and infusion therapy offerings will bring a comprehensive portfolio of infusion products to U.S. hospitals. The purchase price will be a combination of US$240 milli...

Read More

ONC ADDRESSES HEALTH IT INFRASTRUCTURE CHALLENGES IN NEW AGENDA

HITInfrastructure | February 27, 2020

news image

Innovative research and scientific breakthroughs may remain stagnant due to difficulties with health IT infrastructure and the lack of quality data, but ONC articulates ways to address these challenges in its new policy and development agenda. A new blog post written by the National Coordinator Don Rucker, MD, and ONC staffers Teresa Zayas Caban, Kevin Chaney, MGS, highlighted the efforts ONC is making to advance the nation’s health IT infrastructure to specifically achieve two goals...

Read More
news image

BIOGX AND BOSCH HEALTHCARE SOLUTIONS ANNOUNCE PARTNERSHIP TO DEVELOP INFECTIOUS DISEASE TESTS FOR THE VIVALYTIC PLATFORM

BioGX and Bosch Healthcare Solutions | May 27, 2020

BioGX and Bosch Healthcare Solutions have partnered to develop point-of-care infectious disease tests for the Bosch Vivalytic all-in-one platform. Vivalytic is a universal sample-to-result platform for molecular diagnostics which can be used at the point-of-need. The patient sample is placed into the test cartridge, which is then inserted into the Vivalytic analyzer. Since the cartridge already contains all the necessary reagents, the test can be conducted with full automation and a faster turna...

Read More
news image

FUTURE OF HEALTHCARE

R1 RCM TO ACQUIRE CLOUDMED, CREATING THE STRATEGIC REVENUE PARTNER FOR HEALTHCARE PROVIDERS

R1 RCM | January 11, 2022

R1 RCM Inc., a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to acquire Cloudmed, a leader in Revenue Intelligence™ solutions for healthcare providers, in an all-stock transaction. The transaction values Cloudmed at approximately $4.1 billion, including $857 million of net debt, based on R1’s closing stock price on January 7, 20...

Read More
news image

HEALTH TECHNOLOGY

IVENIX TO BE ACQUIRED BY FRESENIUS KABI

Ivenix | April 01, 2022

Ivenix, Inc. announced that it has entered into a definitive agreement to be acquired by Fresenius Kabi, a global health care leader specializing in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Ivenix’s advanced infusion system combined with Fresenius Kabi’s intravenous fluids and infusion therapy offerings will bring a comprehensive portfolio of infusion products to U.S. hospitals. The purchase price will be a combination of US$240 milli...

Read More
news image

ONC ADDRESSES HEALTH IT INFRASTRUCTURE CHALLENGES IN NEW AGENDA

HITInfrastructure | February 27, 2020

Innovative research and scientific breakthroughs may remain stagnant due to difficulties with health IT infrastructure and the lack of quality data, but ONC articulates ways to address these challenges in its new policy and development agenda. A new blog post written by the National Coordinator Don Rucker, MD, and ONC staffers Teresa Zayas Caban, Kevin Chaney, MGS, highlighted the efforts ONC is making to advance the nation’s health IT infrastructure to specifically achieve two goals...

Read More